InBALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease

被引:105
作者
Himmelrich, H
Launois, P
Maillard, I
Biedermann, T
Tacchini-Cottier, F
Locksley, RM
Röcken, M [1 ]
Louis, JA
机构
[1] Univ Lausanne, Inst Biochem, WHO, Immunol Res & Training Ctr, CH-1066 Epalinges, Switzerland
[2] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland
[3] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Immunol Microbiol, San Francisco, CA 94143 USA
[6] Univ Munich, Dept Dermatol, D-8000 Munich, Germany
关键词
D O I
10.4049/jimmunol.164.9.4819
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
contrast to intact BALB/c mice, BALB/c mice rendered deficient in V beta 4(+) CD4(+) T cells develop a Th1 response to infection with Leishmania major and are resistant. V beta 4-deficient BALB/c mice are unable to generate the early IL-4 transcription occurring in V beta 4 V alpha 8 CD4(+) T cells of BALB/c mice within 1 day of infection. Here we demonstrate that treatment of V beta 4-deficient BALB/c mice with IL-4 during the first 64 h after infection instructs Th2 cell development and susceptibility to infection. The demonstrated inability of IL-4 to reverse the resistant phenotype of BALB/c mice treated with anti-CD4 mAb the day before infection suggest that these effects of IL-4 require its interaction,vith CD4(+) T cells. In contrast to draining lymph node cells from BALB/c mice, cells from V beta 4-deficient BALB/c mice remain responsive to IL-12 following infection. Strikingly, administration of IL-4 to V beta 4-deficient BALB/c mice renders their lymph node cells unresponsive to IL-12 by down-regulating IL-12R beta 2-chain expression. This study directly demonstrates that in BALB/c mice IL-4 is necessary and sufficient to initiate the molecular events steering Th2 cell maturation and susceptibility to L. major.
引用
收藏
页码:4819 / 4825
页数:7
相关论文
共 43 条
  • [1] CHATELAIN R, 1992, J IMMUNOL, V148, P1182
  • [2] CHUA AO, 1995, J IMMUNOL, V155, P4286
  • [3] USE OF THE CTL44 CELL-LINE, A DERIVATIVE OF CTL/L CELLS, TO IDENTIFY AND QUANTIFY MOUSE INTERLEUKIN-4 BY BIOASSAY
    FAVRE, N
    ERB, P
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 164 (02) : 213 - 220
  • [4] Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984
  • [5] HEINZEL FP, 1995, J IMMUNOL, V155, P730
  • [6] AN EXOGENOUS MOUSE MAMMARY-TUMOR VIRUS WITH PROPERTIES OF MLS-1A (MTV-7)
    HELD, W
    SHAKHOV, AN
    WAANDERS, G
    SCARPELLINO, L
    LUETHY, R
    KRAEHENBUHL, JP
    MACDONALD, HR
    ACHAORBEA, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) : 1623 - 1633
  • [7] Himmelrich H, 1998, J IMMUNOL, V161, P6156
  • [8] DEVELOPMENT OF TH1 CD4+ T-CELLS THROUGH IL-12 PRODUCED BY LISTERIA-INDUCED MACROPHAGES
    HSIEH, CS
    MACATONIA, SE
    TRIPP, CS
    WOLF, SF
    OGARRA, A
    MURPHY, KM
    [J]. SCIENCE, 1993, 260 (5107) : 547 - 549
  • [9] DIFFERENTIAL REGULATION OF T-HELPER PHENOTYPE DEVELOPMENT BY INTERLEUKIN-4 AND INTERLEUKIN-10 IN AN ALPHA-BETA-T-CELL-RECEPTOR TRANSGENIC SYSTEM
    HSIEH, CS
    HEIMBERGER, AB
    GOLD, JS
    OGARRA, A
    MURPHY, KM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) : 6065 - 6069
  • [10] Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major
    Jones, D
    Elloso, MM
    Showe, L
    Williams, D
    Trinchieri, G
    Scott, P
    [J]. INFECTION AND IMMUNITY, 1998, 66 (08) : 3818 - 3824